1. Home
  2. RGEN vs HOMB Comparison

RGEN vs HOMB Comparison

Compare RGEN & HOMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • HOMB
  • Stock Information
  • Founded
  • RGEN 1981
  • HOMB 1998
  • Country
  • RGEN United States
  • HOMB United States
  • Employees
  • RGEN N/A
  • HOMB N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • HOMB Major Banks
  • Sector
  • RGEN Health Care
  • HOMB Finance
  • Exchange
  • RGEN Nasdaq
  • HOMB Nasdaq
  • Market Cap
  • RGEN 6.5B
  • HOMB 5.6B
  • IPO Year
  • RGEN N/A
  • HOMB 2006
  • Fundamental
  • Price
  • RGEN $145.83
  • HOMB $27.85
  • Analyst Decision
  • RGEN Buy
  • HOMB Hold
  • Analyst Count
  • RGEN 11
  • HOMB 6
  • Target Price
  • RGEN $167.90
  • HOMB $31.83
  • AVG Volume (30 Days)
  • RGEN 929.7K
  • HOMB 1.1M
  • Earning Date
  • RGEN 11-11-2025
  • HOMB 10-15-2025
  • Dividend Yield
  • RGEN N/A
  • HOMB 2.87%
  • EPS Growth
  • RGEN N/A
  • HOMB 14.00
  • EPS
  • RGEN N/A
  • HOMB 2.19
  • Revenue
  • RGEN $673,956,000.00
  • HOMB $1,007,568,000.00
  • Revenue This Year
  • RGEN $16.77
  • HOMB $12.79
  • Revenue Next Year
  • RGEN $13.79
  • HOMB $2.84
  • P/E Ratio
  • RGEN N/A
  • HOMB $12.74
  • Revenue Growth
  • RGEN 8.73
  • HOMB 3.66
  • 52 Week Low
  • RGEN $102.97
  • HOMB $24.22
  • 52 Week High
  • RGEN $182.52
  • HOMB $32.91
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 68.33
  • HOMB 36.82
  • Support Level
  • RGEN $121.25
  • HOMB $27.81
  • Resistance Level
  • RGEN $125.90
  • HOMB $28.68
  • Average True Range (ATR)
  • RGEN 5.31
  • HOMB 0.51
  • MACD
  • RGEN 2.79
  • HOMB -0.13
  • Stochastic Oscillator
  • RGEN 84.15
  • HOMB 0.49

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About HOMB Home BancShares Inc.

Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The bank also emphasizes attracting experienced bankers, credit quality and a solid balance sheet. The bank's main source of net revenue is net interest income.

Share on Social Networks: